iRadimed Corporation Stock News

IRADIMED CORPORATION (IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s President and Chief Executive Officer after the departure of

Q1 2020 IRadimed Corp Earnings Call

WINTER SPRINGS, Fla., May 11, 2020 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on.

Kimco Realty Corp (NYSE:KIM) Q1 2020 Results Conference Call May 08, 2020 08:30 AM ET Company Participants David Bujnicki - Senior Vice President of Investor Re

May 02, 2020 (CDN Newswire via Comtex) -- Global Musculoskeletal Diseases Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025...

Earlier, IRadimed released financial results for first-quarter 2020. The agenda for today's call will be as follows: Leslie McDonnell, president and chief executive officer of IRadimed, will present

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of iRadimed (NASDAQ:IRMD) rose 0.2% after the company reported Q1 results.Quarterly Results Earnings per share were up 38.46% year over year to $0.18, which beat the estimate of $0.15.Revenue o

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu

Reports first quarter 2020 revenue of $8.7 million, GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.18Reports combined cash and investments of $47.4 million as of March.